Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001193125-25-250332

President, CEO and CFO bought 125 shares at $5.49 ($687)

  • President, CEO and CFO acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Quinn William P. President, CEO and CFO 2025-06-06 Purchase +125 $5.49 $687 2,188 D
Quinn William P. President, CEO and CFO 2025-10-22 Grant or award +40,000 42,188 D
Open-market purchases · 125 sh · avg $5.49 · $687
Loading xslF345X05/ownership.xml…